Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker

Authors: Flavio Solca, G. Dahl, Andreas Zoephel, Gerd Bader, Michael P. Sanderson, Christian Klein, Oliver Kraemer, Frank Himmelsbach, Eric Haaksma, Guenther R. Adolf - Journal of Pharmacology and Experimental Therapeutics 2012 cited by 867